New C. Diff. Therapy May Be Less Effective Than Traditional Therapy
Researchers compared effectiveness of two therapies for C. diff infections: fecal microbiota spores and traditional fecal transplants.
Researchers compared effectiveness of two therapies for C. diff infections: fecal microbiota spores and traditional fecal transplants.
Researchers compared effectiveness of two therapies for C. diff infections: fecal microbiota spores and traditional fecal transplants.
Read MoreA single dose of nirsevimab was effective in reducing visits to the ED for all-cause bronchiolitis by 55.4%, as well as reducing the risk of hospital admission for RSV bronchiolitis by 87.6%.
Read MoreCancer patients in both hospital and outpatient settings are at a substantially higher risk of developing antimicrobial resistant infections compared to all other non-cancer patients.
Read MoreCommunity-acquired pneumonia is one of the most common infections in children worldwide and represents one of the most frequent and costliest reasons US children are hospitalized.
Read MoreEnterovirus D68 (EV-D68) can cause severe respiratory illness in otherwise healthy children of all ages, and hospitalized children with non-asthma underlying conditions may be at higher risk for severe outcomes.
Read MorePhage therapy—the use of viruses, or phages, to target and kill bacteria—improved lung function and reduced sputum P. aeruginosa in patients with cystic fibrosis.
Read MoreA total of 106 mumps cases have been documented in 24 states and New York City, according to an update by the CDC.
Read MoreDuring the COVID-19 pandemic, hospital-onset antimicrobial-resistant (AMR) infections increased by 6.5% and remained 11.6% above baseline by March 2022.
Read MoreAdults who were hospitalized for a severe infection, such as respiratory infections or sepsis, were more than twice as likely to develop heart failure years later.
Read MoreNasal bacteria can affect the levels of key proteins the SARS-CoV-2 virus needs to enter human cells and may explain why some individuals are more susceptible to COVID-19 infection.
Read MoreA smartphone-sized, battery-powered lab-in-tube assay (LIT) provides a cost-effective tool that can improve TB diagnoses, particularly in resource-limited rural areas.
Read MoreOvershadowed by the current measles epidemic is the fact that whooping cough cases are rising due to drops in vaccination rates.
Read MoreA second school-aged child has died of measles infection in Texas, the third fatality nationwide in 2025.
Read MoreScientists are developing sensor-based tests to quickly detect superbugs like K. pneumoniae, S. aureus, and P. aeruginosa.
Read MoreA recent CDC statement may signal a shift in the agency’s longstanding practice of advocating vaccinations for infectious diseases like measles.
Read MoreThe actor best known for his roles in Top Gun, Tombstone, Heat, Batman Forever, and The Doors, passed away Tuesday at the age of 65 due to pneumonia.
Read MoreThe Louisiana Surgeon General’s Office is reporting two infant deaths as a result of pertussis (whooping cough) “within the last six months.”
Read MoreThe ECRI’s annual list of patient safety threats includes healthcare-associated infections and medical misinformation, but it’s topped by a particular physician behavior towards patients and caregivers that can lead to a loss of trust.
Read MoreAn unidentified respiratory virus is suspected to be the sole cause of Kawasaki disease, a rare condition that typically affects children under five-years-old.
Read MorePatients hospitalized for respiratory infections or sepsis had more than double the odds of heart failure later in life.
Read MoreThe CDC says a total of 1,001 confirmed measles cases have been reported by 30 states, including Texas, which now has 709 cases.
Read MoreThe Study of Tecovirimat for Mpox (STOMP) began in September 2022 as part of the US whole-of-government response to the clade II mpox outbreak.
Read MoreThe New Mexico Department of Health is reporting 30 infections, while one international traveler in Maryland was confirmed positive.
Read MoreA copper-impregnated surface significantly reduced C. difficile spores by over 97% within four hours, offering continuous antimicrobial protection.
Read More